※追記更新（2021.02.06）
2/4付の米国FDAによるCOVID-19絡みガイダンス等の発出について、筆者のお好みでお伝えします。
関係者および興味のある方は、下記URLsの更新通知等をご参照ください。
l2/4付News Release「Coronavirus (COVID-19) Update: FDA Continues Important Work to Support Medical Product Development to Address New Virus Variants」
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-continues-important-work-support-medical-product-development-address
［2/6付追記更新：上記関連ニュース記事］
l2/5付RAPS「Woodcock: FDA plans guidance to address new COVID-19 variants」
https://www.raps.org/news-and-articles/news-articles/2021/2/woodcock-fda-plans-guidance-to-address-new-covid-1
l2/4付News Release「Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Janssen Biotech Inc.’s COVID-19 Vaccine Candidate」
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-announces-advisory-committee-meeting-discuss-janssen-biotech-incs
［2/6付追記更新：上記関連ニュース記事］
l2/5付RAPS「J&J's COVID vaccine headed for VRBPAC on 26 February」
https://www.raps.org/news-and-articles/news-articles/2021/2/jjs-covid-vaccine-headed-for-vrbpac-on-26-february
l2/4付Updated「Notifications and Emergency Use Authorizations: FAQs on Testing for SARS-CoV-2」
https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/notifications-and-emergency-use-authorizations-faqs-testing-sars-cov-2
l2/4付Updated 「Removal Lists of Tests that Should No Longer Be Used and/or Distributed for COVID-19: FAQs on Testing for SARS-CoV-2」
https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/removal-lists-tests-should-no-longer-be-used-andor-distributed-covid-19-faqs-testing-sars-cov-2
2/4付の米国FDAによるCOVID-19絡みガイダンス等の
関係者および興味のある方は、下記URLsの更新通知等をご参照
l2/4付News Release「Coronavirus (COVID-19) Update: FDA Continues Important Work to Support Medical Product Development to Address New Virus Variants」
https://www.fda.gov/news-
［2/6付追記更新：上記関連ニュース記事］
l2/5付RAPS「Woodcock: FDA plans guidance to address new COVID-19 variants」
https://www.raps.org/news-and-
l2/4付News Release「Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Janssen Biotech Inc.’s COVID-19 Vaccine Candidate」
https://www.fda.gov/news-
［2/6付追記更新：上記関連ニュース記事］
l2/5付RAPS「J&J's COVID vaccine headed for VRBPAC on 26 February」
https://www.raps.org/news-and-
l2/4付Updated「Notifications and Emergency Use Authorizations: FAQs on Testing for SARS-CoV-2」
https://www.fda.gov/medical-
l2/4付Updated 「Removal Lists of Tests that Should No Longer Be Used and/or Distributed for COVID-19: FAQs on Testing for SARS-CoV-2」
https://www.fda.gov/medical-
執筆者について
経歴 ※このプロフィールは掲載記事執筆時点での内容となります
コメント
/
/
/
コメント